European Commission approves Actemra/RoActemra by Roche to treat severe COVID-19
Approval based on results from four phase-III studies in motre than 5,500 patients
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Actemra
US approves Roche drug for emergency use against severe COVID-19
The US Food and Drug Administration (FDA) said yesterday that it had issued an emergency use authorisation (EUA) for Actemra to…
New products to drive systemic sclerosis market to $1.8 bn by 2030: GlobalData
GlobalData expects Ofev and Actemra/RoActemra to reach peak global sales of $508.8 million in 2025 and $163.2 million in 2024,…
Roche gives Tocilizumab worth over Rs 40 crores to MoHFW
The supplies reached India on May 11, 2021, and will be handed over to the MohFW in the next few days
Actemra/RoActemra, arthritis drug from Roche fails to meet primary endpoint of COVID-19 trial
The COVACTA study did not meet its primary endpoint of improved clinical status in hospitalised adult patients with severe…
Maha FDA files FIR against five people, guilty in blackmarketing of remedisivir and tocilizumab
The team seized medicines worth Rs 3,13,482 for COVID-19 and other therapeutic categories Amidst the rise of COVID-19 positive…
We are monitoring sale, supply of medicines for COVID-19 treatment: Haryana FDA
Haryana Medical Services Corporation (HMSC) has procured 400 vials of remdesivir and tocilizumab from Cipla to ensure availability…
China approves use of Roche arthritis drug for some Covid-19 patients
Tocilizumab, sold by the Swiss pharma giant under the trade name Actemra, can be prescribed to coronavirus patients who show…